FDA.reportPublic FDA data

Lactobacillus Tablets

Manufacturer
Marlex Pharmaceuticals Inc
Effective date
2020-10-06
Label type
DIETARY SUPPLEMENT
Version
1
Source
full-release
Hydrated at
2026-06-01 02:49:44

Label at a glance#

ProductLactobacillus
Active ingredientLACTOBACILLUS ACIDOPHILUS, LACTOBACILLUS DELBRUECKII BULGARICUS
Label structure5 sections

Dosage and administration

Adults, take four (4) tablets 3 to 4 times daily as dietary supplement. May be followed by a small amount of milk, fruit juice or water.

Label contents#

Full prescribing information#

Supplement Facts

STATEMENT OF IDENTITY SECTION

Supplement Facts
Serving Size: 4 Tablet
Serving per container: 12.5
Amount
Per serving		% Daily
Value*
Total Carbohydrates1g<1 %
Sugars<1g**
Lactobacillus Acidophilus0.2mg Ϯ **
Lactobacillus Bulgaricus0.2mg Ϯ **

Lactobacillus Tablets

*Percent Daily Values are based on a 2,000 Calorie Diet

** Daily Values are not established

Ϯ 0.2mg equals 2 million CFU’s. Each tablet formulated with one million Colony Forming Units (CFU) of the combined active ingredients at the time of manufacturer.

   

Directions:

DOSAGE & ADMINISTRATION SECTION

Adults, take four (4) tablets 3 to 4 times daily as dietary supplement. May be followed by a small amount of milk, fruit juice or water.

Warnings:

WARNINGS SECTION

Do not use if sensitive to milk products.

Keep out of the reach of children.

Other Information:

SAFE HANDLING WARNING SECTION

Store in a cool, dry place at controlled room temperature 15-30°C (59-86°F)

Inactive Ingredients:

Dicalcium Phosphate, Colloidal Silicon Dioxide, Croscarmellose Sodium, Microcrystalline Cellulose, Magnesium Stearate, Stearic Acid.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Manufactured for/ Distributed by:

Marlex Pharmaceuticals, Inc.

New Castle, DE 19720

Rev. 6/20 GP

PRINCIPAL DISPLAY PANEL Manufactured for/ Distributed by: Marlex Pharmaceuticals, Inc. New Castle, DE 19720 Rev. 6/20 GPPRINCIPAL DISPLAY PANEL Manufactured for/ Distributed by: Marlex Pharmaceuticals, Inc. New Castle, DE 19720 Rev. 6/20 GP

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1293033Lactobacillus acidophilus 0.2 MG / Lactobacillus bulgaricus 0.2 MG Oral TabletPSN1
1293033Lactobacillus acidophilus 0.2 MG / Lactobacillus delbrueckii subsp. bulgaricus 0.2 MG Oral TabletSCD1

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
10135-705-50Lactobacillus50 in 1 BOTTLETABLET501

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10135-705LACTOBACILLUS (LACTOBACILLUS ACIDOPHILUS) TABLET [MARLEX PHARMACEUTICALS INC]11 package rows20201003_afa81aad-6ada-4275-9946-e9fceb62bfe9.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 9 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10135-70510135-705-50

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 8 matching rows.

Name, UNII, Kind table
NameUNIIKind
LACTOBACILLUS ACIDOPHILUS1PRR1V42V5ACTIB
LACTOBACILLUS DELBRUECKII BULGARICUSHU1W4L947HACTIB
CALCIUM PHOSPHATE, DIBASIC, ANHYDROUSL11K75P92JIACT
SILICON DIOXIDEETJ7Z6XBU4IACT
CROSCARMELLOSE SODIUMM28OL1HH48IACT
MICROCRYSTALLINE CELLULOSEOP1R32D61UIACT
MAGNESIUM STEARATE70097M6I30IACT
STEARIC ACID4ELV7Z65APIACT

Source Document#

Source XML

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.